Natixis’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,512
Closed -$54.6K 987
2024
Q1
$54.6K Sell
2,512
-2,092
-45% -$45.5K ﹤0.01% 802
2023
Q4
$43.3K Buy
+4,604
New +$43.3K ﹤0.01% 819